Published in Nature on September 17, 1992
Vasopressin increases water permeability of kidney collecting duct by inducing translocation of aquaporin-CD water channels to plasma membrane. Proc Natl Acad Sci U S A (1995) 4.35
Genetic kidney diseases. Lancet (2010) 2.00
Individuality of the plasma sodium concentration. Am J Physiol Renal Physiol (2014) 1.49
Cloning, characterization, and chromosomal mapping of human aquaporin of collecting duct. J Clin Invest (1994) 1.45
Identification of novel rhodopsin mutations responsible for retinitis pigmentosa: implications for the structure and function of rhodopsin. Am J Hum Genet (1993) 1.45
An aquaporin-2 water channel mutant which causes autosomal dominant nephrogenic diabetes insipidus is retained in the Golgi complex. J Clin Invest (1998) 1.45
Hereditary isolated glucocorticoid deficiency is associated with abnormalities of the adrenocorticotropin receptor gene. J Clin Invest (1993) 1.34
Water channels encoded by mutant aquaporin-2 genes in nephrogenic diabetes insipidus are impaired in their cellular routing. J Clin Invest (1995) 1.32
X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis. J Clin Invest (1993) 1.31
An impaired routing of wild-type aquaporin-2 after tetramerization with an aquaporin-2 mutant explains dominant nephrogenic diabetes insipidus. EMBO J (1999) 1.31
Patients with autosomal nephrogenic diabetes insipidus homozygous for mutations in the aquaporin 2 water-channel gene. Am J Hum Genet (1994) 1.30
Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidus. Am J Hum Genet (1994) 1.30
Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors. J Clin Invest (1993) 1.28
Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist. J Clin Invest (1996) 1.28
Arg60 to Leu mutation of the human thromboxane A2 receptor in a dominantly inherited bleeding disorder. J Clin Invest (1994) 1.23
Comparative sequence and structural analyses of G-protein-coupled receptor crystal structures and implications for molecular models. PLoS One (2009) 1.12
Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a co-expressed receptor polypeptide. EMBO J (1996) 1.10
Cyclic AMP is sufficient for triggering the exocytic recruitment of aquaporin-2 in renal epithelial cells. EMBO Rep (2003) 1.09
Binding-, intracellular transport-, and biosynthesis-defective mutants of vasopressin type 2 receptor in patients with X-linked nephrogenic diabetes insipidus. J Clin Invest (1995) 1.09
G protein subunits and the stimulation of phospholipase C by Gs-and Gi-coupled receptors: Lack of receptor selectivity of Galpha(16) and evidence for a synergic interaction between Gbeta gamma and the alpha subunit of a receptor activated G protein. Proc Natl Acad Sci U S A (1996) 1.08
Beta1-integrin is required for kidney collecting duct morphogenesis and maintenance of renal function. Am J Physiol Renal Physiol (2009) 1.07
Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment. Endocr Rev (2013) 1.06
Rare inherited kidney diseases: challenges, opportunities, and perspectives. Lancet (2014) 1.04
Reconstitution of mutant V2 vasopressin receptors by adenovirus-mediated gene transfer. Molecular basis and clinical implication. J Clin Invest (1997) 1.03
Heterogeneous AVPR2 gene mutations in congenital nephrogenic diabetes insipidus. Am J Hum Genet (1994) 1.02
Collecting duct principal cell transport processes and their regulation. Clin J Am Soc Nephrol (2014) 1.02
Sequence-specific "gene signatures" can be obtained by PCR with single specific primers at low stringency. Proc Natl Acad Sci U S A (1994) 1.01
GPR48 increases mineralocorticoid receptor gene expression. J Am Soc Nephrol (2011) 0.99
Quality control for unfolded proteins at the plasma membrane. J Cell Biol (2010) 0.96
Chaperoning G protein-coupled receptors: from cell biology to therapeutics. Endocr Rev (2014) 0.91
Abnormalities in G protein-coupled signal transduction pathways in human disease. J Clin Invest (1993) 0.91
Genetic variations in human G protein-coupled receptors: implications for drug therapy. AAPS PharmSci (2001) 0.86
Congenital nephrogenic diabetes insipidus presented with bilateral hydronephrosis: genetic analysis of V2R gene mutations. Yonsei Med J (2006) 0.84
Aquaporin-2: new mutations responsible for autosomal-recessive nephrogenic diabetes insipidus-update and epidemiology. Clin Kidney J (2012) 0.84
Correction of renal tubular acidosis in carbonic anhydrase II-deficient mice with gene therapy. J Clin Invest (1998) 0.83
Nephrogenic syndrome of inappropriate antidiuresis. Int J Pediatr (2012) 0.82
Heritability of serum sodium concentration: evidence for sex- and ethnic-specific effects. Physiol Genomics (2011) 0.81
Treatment of nephrogenic diabetes insipidus with hydrochlorothiazide and amiloride. Arch Dis Child (1999) 0.81
Membrane protein stability analyses by means of protein energy profiles in case of nephrogenic diabetes insipidus. Comput Math Methods Med (2012) 0.80
Deletion of the V2 vasopressin receptor gene in two Chinese patients with nephrogenic diabetes insipidus. BMC Genet (2006) 0.80
Novel mutations associated with nephrogenic diabetes insipidus. A clinical-genetic study. Eur J Pediatr (2015) 0.80
Analysis of a novel AVPR2 mutation in a family with nephrogenic diabetes insipidus. Int J Clin Exp Med (2010) 0.79
Visualizing microtubule-dependent vasopressin type 2 receptor trafficking using a new high-affinity fluorescent vasopressin ligand. Endocrinology (2011) 0.77
A novel v2 vasopressin receptor mutation with x-linked nephrogenic diabetes insipidus. Clin Pediatr Endocrinol (2006) 0.77
Missorting of the Aquaporin-2 mutant E258K to multivesicular bodies/lysosomes in dominant NDI is associated with its monoubiquitination and increased phosphorylation by PKC but is due to the loss of E258. Pflugers Arch (2007) 0.76
Nephrogenic diabetes insipidus: an X chromosome-linked dominant inheritance pattern with a vasopressin type 2 receptor gene that is structurally normal. Proc Natl Acad Sci U S A (1994) 0.75
Common α2A and α2C adrenergic receptor polymorphisms do not affect plasma membrane trafficking. Naunyn Schmiedebergs Arch Pharmacol (2014) 0.75
AQP2 Plasma Membrane Diffusion Is Altered by the Degree of AQP2-S256 Phosphorylation. Int J Mol Sci (2016) 0.75
Immunological profile in a family with nephrogenic diabetes insipidus with a novel 11 kb deletion in AVPR2 and ARHGAP4 genes. BMC Med Genet (2008) 0.75
5. Hereditary Kidney Disorders. EJIFCC (2009) 0.75
Urinary concentration: different ways to open and close the tap. Pediatr Nephrol (2013) 0.75
A novel mutation in AVPR2 causing congenital nephrogenic diabetes insipidus with complete resistance to antidiuretic hormone. NDT Plus (2008) 0.75
Evolutionary Influenced Interaction Pattern as Indicator for the Investigation of Natural Variants Causing Nephrogenic Diabetes Insipidus. Comput Math Methods Med (2015) 0.75
NFAT5 and SLC4A10 Loci Associate with Plasma Osmolality. J Am Soc Nephrol (2017) 0.75
A novel AVPR2 gene mutation of X-linked congenital nephrogenic diabetes insipidus in an Asian pedigree. J Int Med Res (2016) 0.75
Wilms tumor arising in a child with X-linked nephrogenic diabetes insipidus. Pediatr Nephrol (2009) 0.75
A peptide derived from a beta2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J Biol Chem (1996) 3.77
Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. J Clin Invest (2000) 2.78
Modulation of Ca(2+) entry by polypeptides of the inositol 1,4, 5-trisphosphate receptor (IP3R) that bind transient receptor potential (TRP): evidence for roles of TRP and IP3R in store depletion-activated Ca(2+) entry. Proc Natl Acad Sci U S A (1999) 2.52
A986S polymorphism of the calcium-sensing receptor and circulating calcium concentrations. Lancet (1999) 2.47
On the molecular basis and regulation of cellular capacitative calcium entry: roles for Trp proteins. Proc Natl Acad Sci U S A (1996) 2.44
Molecular cloning of the receptor for human antidiuretic hormone. Nature (1992) 2.44
Nephrogenic diabetes insipidus. Annu Rev Physiol (2001) 2.38
Nucleotide sequence of cloned cDNAs encoding human preproparathyroid hormone. Proc Natl Acad Sci U S A (1981) 2.36
Nucleotide sequence of the human parathyroid hormone gene. Proc Natl Acad Sci U S A (1983) 2.35
Urinary excretion of aquaporin-2 in patients with diabetes insipidus. N Engl J Med (1995) 2.33
Targeted ablation of the 25-hydroxyvitamin D 1alpha -hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. Proc Natl Acad Sci U S A (2001) 2.30
Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type beta signaling. Proc Natl Acad Sci U S A (2001) 1.88
Evidence for a third genetic locus for autosomal dominant polycystic kidney disease. Genomics (1995) 1.86
Ns and Ni, the stimulatory and inhibitory regulatory components of adenylyl cyclases. Purification of the human erythrocyte proteins without the use of activating regulatory ligands. J Biol Chem (1984) 1.62
Pharmacological chaperones: a new twist on receptor folding. Trends Pharmacol Sci (2000) 1.61
Nephrogenic diabetes insipidus. A V2 vasopressin receptor unable to stimulate adenylyl cyclase. J Biol Chem (1993) 1.55
Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus. N Engl J Med (1988) 1.54
The transcription factor SOX9 regulates cell cycle and differentiation genes in chondrocytic CFK2 cells. J Biol Chem (2001) 1.51
Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis. N Engl J Med (1982) 1.48
An aquaporin-2 water channel mutant which causes autosomal dominant nephrogenic diabetes insipidus is retained in the Golgi complex. J Clin Invest (1998) 1.45
The gene responsible for pseudohypoparathyroidism type Ib is paternally imprinted and maps in four unrelated kindreds to chromosome 20q13.3. Proc Natl Acad Sci U S A (1998) 1.43
Molecular cloning and expression of a fifth muscarinic acetylcholine receptor. J Biol Chem (1989) 1.35
The relationship among carbon dioxide pneumoperitoneum, vasopressin release, and hemodynamic changes. Anesth Analg (1999) 1.34
Subunit II of cytochrome c oxidase in Chlamydomonad algae is a heterodimer encoded by two independent nuclear genes. J Biol Chem (2000) 1.34
X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis. J Clin Invest (1993) 1.31
Molecular cloning of the chicken progesterone receptor. Science (1986) 1.30
beta2-adrenergic receptor desensitization, internalization, and phosphorylation in response to full and partial agonists. J Biol Chem (1997) 1.30
The long and the short cycle. Alternative intracellular routes for trafficking of G-protein-coupled receptors. J Biol Chem (2001) 1.30
Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidus. Am J Hum Genet (1994) 1.30
Studies of circulating parathyroid hormone in man using a homologous amino-terminal specific immunoradiometric assay. Clin Endocrinol (Oxf) (1980) 1.29
Hyponatremia in cirrhosis: from pathogenesis to treatment. Hepatology (1998) 1.27
An X-linked NDI mutation reveals a requirement for cell surface V2R expression. Mol Endocrinol (1997) 1.22
A radioimmunoassay for 1,25-dihydroxycholecalciferol. Clin Sci Mol Med (1978) 1.22
A simplified assessment of response to parathyroid hormone in hypoparathyroid patients. Lancet (1976) 1.19
Regulation of human tonsillar T-cell proliferation by the active metabolite of vitamin D3. Immunology (1986) 1.19
Phosphorylation of the V2 vasopressin receptor. J Biol Chem (1997) 1.18
Mapping of human X-linked hypophosphataemic rickets by multilocus linkage analysis. Hum Genet (1986) 1.17
Report of 33 novel AVPR2 mutations and analysis of 117 families with X-linked nephrogenic diabetes insipidus. J Am Soc Nephrol (2000) 1.17
Modulation of plasma and platelet vasopressin by cardiac function in patients with heart failure. Kidney Int (1986) 1.16
Human parathyroid hormone gene (PTH) is on short arm of chromosome 11. Somatic Cell Genet (1983) 1.16
Enzymic characterization of murine and human prohormone convertase-1 (mPC1 and hPC1) expressed in mammalian GH4C1 cells. Biochem J (1993) 1.16
Dual signaling potential is common among Gs-coupled receptors and dependent on receptor density. Mol Pharmacol (1994) 1.16
Salmeterol-induced desensitization, internalization and phosphorylation of the human beta2-adrenoceptor. Br J Pharmacol (1998) 1.16
Regulation of MHC class I and beta 2-microglobulin gene expression in human neuronal cells. Factor binding to conserved cis-acting regulatory sequences correlates with expression of the genes. J Immunol (1993) 1.15
In vitro characterization of the novel proprotein convertase PC7. J Biol Chem (1997) 1.14
Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype. J Clin Invest (1994) 1.13
Structure and chromosomal localization of the human antidiuretic hormone receptor gene. Am J Hum Genet (1992) 1.10
Three families with autosomal dominant nephrogenic diabetes insipidus caused by aquaporin-2 mutations in the C-terminus. Am J Hum Genet (2001) 1.10
Rat parathyroid hormone-like peptide: comparison with the human homologue and expression in malignant and normal tissue. Mol Endocrinol (1989) 1.09
Reversible resistance to the renal action of parathyroid hormone in human vitamin D deficiency. Clin Sci (Lond) (1982) 1.09
Insertion of an Alu sequence in the Ca(2+)-sensing receptor gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Am J Hum Genet (1995) 1.09
Human chromogranin A gene. Molecular cloning, structural analysis, and neuroendocrine cell-specific expression. J Biol Chem (1994) 1.08
Baseline characteristics of patients enrolled in the Canadian Fabry Disease Initiative. Mol Genet Metab (2009) 1.08
A serine cluster prevents recycling of the V2 vasopressin receptor. Proc Natl Acad Sci U S A (1998) 1.07
Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: molecular basis of a mild clinical phenotype. J Am Soc Nephrol (1998) 1.06
Complete amino acid sequence of human parathyroid hormone. Biochemistry (1978) 1.06
Occupancy of upstream regulatory sites in vivo coincides with major histocompatibility complex class I gene expression in mouse tissues. Mol Cell Biol (1992) 1.06
Vitamin D-dependent rickets type II: extreme end organ resistance to 1,25-dihydroxy vitamin D3 in a patient without alopecia. Eur J Pediatr (1986) 1.06
Measurement of 1,25-dihydroxycholecalciferol in man by radioimmunoassay. Clin Endocrinol (Oxf) (1979) 1.05
Association of calnexin with wild type and mutant AVPR2 that causes nephrogenic diabetes insipidus. Biochemistry (2001) 1.05
Biochemical basis of partial nephrogenic diabetes insipidus phenotypes. Mol Endocrinol (1997) 1.04
Characterization of the human parathyroid hormone-like peptide gene. Functional and evolutionary aspects. J Biol Chem (1989) 1.03
X-linked nephrogenic diabetes insipidus: from the ship Hopewell to RFLP studies. Am J Hum Genet (1992) 1.02
Interrelationship between cardiac output and vascular resistance as determinants of effective arterial blood volume in cirrhotic patients. Kidney Int (1985) 1.02
Vasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: analysis of expression, processing, and function. Mol Pharmacol (1996) 1.01
Influence of calcium and 1,25-dihydroxycholecalciferol on proliferation and proto-oncogene expression in primary cultures of bovine parathyroid cells. Endocrinology (1989) 1.00
A Phase 2 study of migalastat hydrochloride in females with Fabry disease: selection of population, safety and pharmacodynamic effects. Mol Genet Metab (2013) 0.99
Galphas transcripts are biallelically expressed in the human kidney cortex: implications for pseudohypoparathyroidism type 1b. J Clin Endocrinol Metab (2001) 0.99
Circulating concentrations of parathyroid hormone-like peptide in malignancy and in hyperparathyroidism. J Bone Miner Res (1990) 0.99
Molecular cloning of a human gene (S31) encoding a novel serotonin receptor mediating inhibition of adenylyl cyclase. FEBS Lett (1992) 0.99
Regulation of parathyroid hormone-like peptide in cultured normal human keratinocytes. Effect of growth factors and 1,25 dihydroxyvitamin D3 on gene expression and secretion. J Clin Invest (1991) 0.98
Cellular responses to stimulation of the M5 muscarinic acetylcholine receptor as seen in murine L cells. J Biol Chem (1990) 0.98
In vitro cleavage of internally quenched fluorogenic human proparathyroid hormone and proparathyroid-related peptide substrates by furin. Generation of a potent inhibitor. J Biol Chem (1998) 0.98
Osmotic and nonosmotic control of vasopressin release and the pathogenesis of impaired water excretion in adrenal, thyroid, and edematous disorders. J Lab Clin Med (1981) 0.98